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Abstract: Platelets are sensitive cells and are easily activated by different stimulants in the circulation system. It is known that tumor
necrosis factor-alpha (TNF-α) is a proinflammatory cytokine and plays a role in inflammation. The role of TNF-α in the apoptotic
process in blood platelets is unknown. In order to study the formation of apoptosis in platelets after incubation with TNF-α and/or
ADP, several biomarkers were chosen: phosphatidylserine (PS) exposure and P-selectin binding; cGMP, Cyt-c, and Ca2+ levels and
NOS activation; and gene and protein expression of caspase-3 and iNOS. Platelets were incubated with 100 pg/mL TNF-α and/or 50
mM iNOS specific inhibitor, such as at 1400 W for 1 h at 37 °C in the presence of 5 µM ADP. According to the results, the levels of PS
exposure and P-selectin binding were significantly higher in TNF-α + ADP platelets, which decreased with the addition of 1400 W.
A significant induction in cGMP, Cyt-c, and Ca2+ levels was observed in platelets treated with TNF-α + ADP. On the other hand, the
upregulation of the apoptotic gene caspase-3 and iNOS expression levels in TNF-α-treated and ADP-activated platelets was significantly
reversed with the addition of 1400 W. These data demonstrate that TNF-α promotes iNOS expression through caspase-3 stimulation in
human platelets, and its concomitance leads to the triggering of apoptosis-mediated inflammation upon platelet activation.
Key words: Platelets, apoptosis, TNF-α, iNOS, caspase-3

1. Introduction
Tumor necrosis factor-alpha (TNF-α) is a potent
proinflammatory cytokine that plays many roles as a
signaling molecule responsible for a diverse range of
signaling within cells and as an effector molecule in
cellular proliferation, differentiation, or cell death. TNF-α
interacts with two distinct cell surface receptors: 55kDa TNF-R1 and 75-kDa TNF-R2 (Wajant et al., 2003).
TNF-R1 is widely expressed in nucleated cell types, and
TNF-R2 is expressed mainly in immune and endothelial
cells. Platelets are small anucleated cells produced
during the blood cell formation in bone marrow, which
plays a critical role in thrombus formation under both
physiological and pathological blood flow conditions
(Deutsch et al., 2006). Platelets stay in the blood circulation
for several days and aggregate in response to stimulants
such as thrombin, collagen, ADP, and epinephrine (Egger
et al., 1998; Yip et al., 2004). Platelets are reported to
undergo apoptosis in vitro and in vivo, although they are
known to be anucleated cells (Josefsson et al., 2012). There
are two major routes by which apoptosis can be induced:
* Correspondence: drozgecevik@gmail.com

the mitochondrial or intrinsic apoptosis pathway, and the
death receptor-mediated or extrinsic apoptosis pathway.
The intrinsic and extrinsic apoptotic pathways converge at
the level of caspase-3 activation. Platelets show many of the
signs of the apoptotic mechanism, such as depolarization
of the mitochondrial membrane potential, microparticle
formation, activation of caspase-3, and exposure of
phosphatidylserine (PS) on the platelet surface (White
et al., 2010). Nitric oxide (NO) is an important signaling
molecule in the body and plays a role in a variety of
biological processes. NO is biosynthesized endogenously
from L-arginine and molecular oxygen in a reaction
catalyzed by various nitric oxide synthase (NOS) enzymes
and by the reduction of inorganic nitrate. Three isoenzymes
of NOS have been described: type I (neuronal isoform,
nNOS), type II (inducible isoform, iNOS), and type III
(endothelial isoform, eNOS), displaying about 50% amino
acid sequence homology (Gaston et al., 1994). NO is an
inhibitor of platelet adhesion, with aggregation produced
either by endothelial cells or by the platelets themselves,
and it contributes to vessel homeostasis by inhibiting
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vascular smooth muscle contraction and formation of
leukocyte–platelet aggregates (Gkaliagkousi et al., 2009).
The expressions of both eNOS and iNOS isoforms of NOS
have been described in platelets, especially eNOS as a
predominant form (Mehta et al., 1995). NO can be produced
by platelets, and although its role has been uncertain, it
is generally suggested that it plays an important role in
modulating platelet function (Gkaliagkousi et al., 2009).
Furthermore, a high concentration of NO stimulation from
iNOS plays a critical role in proapoptotic response and cell
damage, yet its function in various cell types is not clear
(Kolb et al., 2000; Bian et al., 2012; Han et al., 2015). The
aim of our study was to investigate the effects of TNF-α on
platelet apoptosis. The main goal of the study was to detect
TNF-α-induced caspase-3 stimulation-related iNOS gene
expression in platelets under in vitro conditions.
2. Materials and methods
2.1. Platelet preparation
Fresh ACD-anticoagulated blood was obtained from 12
healthy volunteers (25–40 years of age) with informed
consent according to the Ethics Committee (No.
2610201006) of Marmara University, Turkey. Volunteers
were not treated with any antiplatelet or antiinflammatory
drug. Platelet-rich plasma (PRP) was separately prepared
by centrifugation at 150 × g for 15 min at room temperature.
The PRP was then recentrifuged at 800 × g for 15 min to
concentrate platelets, and the pellet was resuspended
in modified Tyrode’s Ca2+/Mg2+-free buffer (127 mM
NaCl, 2.7 mM KCl, 0.5 mM NaH2PO4, 12 mM NaHCO3,
5 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic
acid (HEPES), 5.6 mM glucose, pH 7.4, and 1 U/mL
apyrase) to obtain a final platelet concentration of 2 × 108/
mL. The platelet suspension was filtered for the removal
of leukocytes using a special filter (Imugard, Terumo).
Platelet counting was performed with a hemocytometer,
and platelet viability and leukocyte contamination were
assessed by performing cytologic studies with trypan
blue and May-Grünwald-Giemsa stains (95%–99% vital
platelets). Platelets were suspended with HEPES buffer and
incubated with a 50 mM, 1400 W iNOS inhibitor (Cayman,
USA) or with 100 pg/mL TNF-α (Invitrogen, CA) for 1 h at
37 °C in the presence of 5 µM ADP. Adenosine diphosphate
(ADP) was used for the stimulation of platelets.
2.2. Platelet activation and phosphatidylserine exposure
assay
Platelet-surface exposure of PS was determined with
the Annexin V-PI Apoptosis Detection Kit (BD, USA)
using flow cytometry according to the manufacturer’s
instructions. Platelet suspensions of 100 µL aliquots each
were placed in siliconized glass cuvettes for PS exposure
experiments and were combined with fluorescein
isothiocyanate (FITC)-conjugated annexin V and
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phycoerythrin (PE)-conjugated propidium iodide. They
were then incubated for 15 min at RT. Samples were
diluted 5-fold with binding buffer for immediate analysis
by flow cytometry.
For the determination of platelet activation, P-selectin
expression was monitored as described previously (Sener
et al., 2012). Platelets were fixed with 2% paraformaldehyde
and incubated for 15 min at RT with 1 µg/mL FITC-labeled
anti-CD62P and were examined by flow cytometry. For
the flow cytometry analyses, all the samples prepared as
described above were analyzed with the Becton-Dickinson
FACScan. The flow cytometer was equipped with a 488
nm argon ion laser. The platelet population was identified
by forward scatter for cell size and by side scatter for cell
granularity. The alignment of the instrument was checked
daily with calibration beads. An electronic bitmap was
placed around the platelet population and CD41a-FITC
was used to form a gate. The results were evaluated as the
percentage of antibody-positive platelets. FITC-conjugated
immunoglobulin G (IgG) was used to determine the
nonspecific and background fluorescence. Fifty thousand
platelets were counted in each tube.
2.3. Measurement of Ca+2 and Cyt-c
Intracellular calcium mobilization of the platelets was
measured with a Fluo-8 No-Wash Calcium Assay Kit (AAT
Bioquest, USA). Fluo-8 solution was added to the platelet
suspensions and the mixture was incubated for 30 min at
37 °C. Ca2+ levels were determined at Ex/Em = 490/525 nm
with a fluorescence microplate reader (Glomax, Promega,
USA). Cytochrome c (Cyt-c) was shown to redistribute
from mitochondria to the cytosol during apoptosis in
cells. The measurement of Cyt-c release in platelets was
performed with the human Cyt-c ELISA Kit (eBioscience,
Germany) as described previously (Dasgupta et al., 2010;
Cevik et al., 2013). Platelets were resuspended with lysis
buffer and then centrifuged at 18,000 × g for 10 min.
Platelet supernatant included cytosolic proteins and was
analyzed by manufacturer protocols with an ELISA reader
(BioTek, USA). Total protein concentration in the samples
was quantified using a Bradford protein assay kit.
2.4. Measurement of cGMP and total NOS activity
Cyclic guanosine monophosphate (cGMP) content was
determined by measuring the generation of cGMP in
platelets with a standard cGMP ELISA kit (eBioscience,
Germany) according to the protocols recommended by
the manufacturer. Samples were run in triplicate, relative
to the cGMP standard curve by use of a microplate reader
(Epoch, BioTek, USA). Results are expressed as picomoles
of cGMP per milligram of total protein. Total NOS activity
was measured with a kit (Oxford Biomedical Research,
NB78, USA) according to the manufacturer’s instructions.
NOS activity was determined with recombinant nitrate
reductase, converting nitrate to nitrite by Griess reagent.
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By using sodium nitrite as the standard curve, the amount
of nitrate conversion to nitrite was measured at 540 nm.
2.5. Western blot analysis for caspase-3 and iNOS
Platelet lysates were suspended in cell lysis buffer (50
mM Tris-HCl, pH 7.4, 0.15 mM NaCl, 1 mM EGTA, 1
mM PMSF, 0.5% Nonidet P40, 0.25% SDS leupeptin, and
aprotinin) and centrifuged for 15 min at 3000 × g at 4 °C. The
supernatant was collected and the protein concentration
was determined with the Bradford protein assay kit. After
adjustment for protein concentration, cell lysates (30 µg
protein) were boiled in Laemmli buffer (62.5 mM TrisHCl, pH 6.8, containing 0.05% 2-mercaptoethanol, 2%
SDS, 10% glycerol, and 0.01% bromphenol blue) and
resolved on 12% SDS-PAGE. They were then transferred to
nitrocellulose membrane, as described previously (Cevik
et al., 2013). The membrane was blocked with 5% nonfat
skim milk powder in Tris-buffered saline (TBS) containing
0.1% Tween-20. The membrane was washed twice in TBST
(5 min each) and incubated overnight with the primary
antibody (1:500 monoclonal human anticaspase-3, antiiNOS, b-actin). The membrane was washed three times
(5 min each) in TBST and then incubated with HRPconjugated secondary antibody for 2 h. After being
washed three times (5 min each), the blot was developed
with a Western Blotting Enhanced Chemiluminescence
Luminol Reagents Kit and exposed to a film to visualize
the protein bands that were scanned with an imaging
system (Kodak, DC290, USA). A representative blot for
each protein of interest is shown, and β-actin was used as
a protein-loading control. Band intensities were quantified
by determining the area under the curve for each band
(ImageJ software 1.43m, National Institutes of Health,
Bethesda, MD, USA). Band intensities were normalized to
the intensity of the corresponding control, and the mean
and SD values are shown.
2.6. Quantitative reverse transcriptase real-time PCR
2.6.1. RNA extraction and reverse transcription
Total RNA was isolated using NucleoSpin RNAII in
compliance with the manufacturer’s instructions. Total
RNA concentrations were determined using the Take3
Multi-Volume Plate (BioTek, USA) according to the
manufacturer’s instructions. A260/A280 ratios were >1.9,
and RNA was stored at –70 °C.
cDNA synthesis was performed using a First-Strand
cDNA Synthesis Kit according to the manufacturer’s
instructions. Reverse transcription of 0.1 µg of total RNA
was carried out in a total volume of 20 µL reaction mixture,
consisting of 10 mM dNTP mix, a reaction buffer, 1 µL
random hexamer, 20 U/µL RNase inhibitor, and 20 U/µL
MuLV reverse transcriptase. Samples were incubated at 25
°C for 5 min, at 37 °C for 60 min, at 70 °C for 5 min, and
finally at 4 °C for 5 min in a GenAmp PCR System 9700
thermal cycler (PE Applied Biosystems, USA).

2.6.2. PCR conditions
Real-time PCR was performed using SYBR Green SuperMix
with approximately 100 ng of cDNA and primers in a total
volume of 20 µL reaction mix, as described previously
(Cevik et al., 2013). PCR was performed at 94 °C for 5 min,
and then 50 cycles for caspase-3 were run at 94 °C for 30 s,
60 °C for 30 s, and 72 °C for 30 s. For iNOS, 50 cycles were
run at 94 °C for 30 s, 60 °C for 30 s, and 74 °C for 35 s. For
GAPDH, 40 cycles were run at 94 °C for 40 s, 60 °C for 30
s, and 68 °C for 40 s on the iQ™5 Optical System (Bio-Rad).
At the end of the amplification cycles, melting temperature
analysis was carried out with a slow increase in temperature
transition rate of 0.1 °C/s up to 95 °C. The primers
used were: iNOS, 5’CAGCGGGATGACTTTCCAA3’
and
5’TGCAGGTCCAAATCTTGCCT3’;
caspase-3,
5’CAGTGGAGGCCGACTTCTTG3’
and
5’ATCCAGTCGCTTTGTGCCA3’;
GAPDH,
5’TGCACCACCAACTGCTTAGC3’
and
5’GGCATGGACTGTGGTCATGAG3’.
Amplification,
data acquisition, and analysis were performed using Qbase
(Bio-Rad, USA). Coupled to the instrument, the software
determines the threshold cycle that represents the number
of cycles in which fluorescence intensity is significantly
above the background fluorescence. The amounts of
caspase-3 relative to the amount of GAPDH in the same
sample were analyzed with the relative quantification
approach. The results are expressed as normalized ratios.
2.7. Statistics
Statistical analysis used multivariate analysis of variance.
Data are presented as the mean ± SD from N independent
experiments. A two-tailed, paired Student’s t-test was used
to compare the test and the control groups. The threshold
for statistical significance was set to P < 0.05.
3. Results
3.1. Platelet activation with TNF-α
Platelet activation was determined quantitatively by
measuring the production of soluble P-selectin. The
changes of the platelet activation markers are shown in
Figure 1A (platelet samples stained with CD62p). The
percentage of CD62p exposure in the ADP group (24.78 ±
4.21%) was significantly different from that of the control
(16.33 ± 2.25%) (P < 0.05). CD62p levels of the TNF-α +
ADP group (44.66 ± 6.03%) were significantly increased
compared to the ADP (P < 0.01). CD62p levels of the
TNF-α + ADP + 1400 W group (32.45 ± 6.05%) decreased
compared to the TNF-α + ADP group, but not significantly
(Figure 1B).
Platelet PS expressions, i.e. early apoptotic markers, are
shown in Figure 1C. Using the annexin-V-FITC antibody
against the platelets, PS expression was measured in
groups by histograms (Figure 1C). PS expression levels in
the ADP group (7.95 ± 2.21%) were significantly higher

33

ÇEVİK et al. / Turk J Biol

Figure 1. A) Histogram samples of control, ADP, ADP + TNF-α, and ADP + TNF-α + 1400 W groups for P-selectin
measurement by flow cytometry. B) Mean values of P-selectin in platelets (+: P < 0.05 versus control group, **: P < 0.01
versus ADP group). C) PS exposure of platelets was determined using annexin-V-FITC in samples of control, ADP, ADP +
TNF-α, and ADP + TNF-α + 1400 W groups. D) Mean values of annexin-V in platelets (+: P < 0.05 versus control group,
***: P < 0.01 versus ADP group, ##: P < 0.01 versus TNF-α + ADP group).

than in the control group (2.33 ± 1.25%) (P < 0.05). In
the TNF-α + ADP group (54.52 ± 6.01%), PS expression
levels were significantly higher than in the ADP group (P
< 0.001), and in the TNF-α + ADP + 1400 W group (12.45
± 6.65%), PS was significantly lower than in the TNF-α +
ADP group (P < 0.01) (Figure 1D).
3.2. The effects of TNF-α on the Ca2+ oscillation and
Cyt-c release in platelets
The contribution of the internal Ca2+ was monitored in
incubated platelets (Figure 2A). ADP-activated platelets
showed higher Ca2+ levels than the control platelets (P <

34

0.001). The internal Ca2+ levels in the TNF-α + ADP group
were increased compared to the ADP group (P < 0.001).
On the other hand, the addition of 1400 W to TNF-α +
ADP-induced platelets caused significant reductions in
Ca2+ levels compared to the TNF-α + ADP group (P <
0.001).
Cyt-c levels of platelets are shown in Figure 2B. After
activation with ADP, there was a significant increase in
the Cyt-c levels as compared to the control platelets (P <
0.05). The addition of TNF-α in ADP-induced platelets
caused significant inductions in Cyt-c levels (P < 0.01). In
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Figure 2. A) Platelet Ca+2 levels (+++: P < 0.001 versus control group, ***: P < 0.001 versus ADP group, ##: P < 0.001 versus
TNF-α + ADP group). B) Platelet Cyt-c levels (+: P < 0.05 versus control group, **: P < 0.01 versus ADP group, ##: P < 0.01
versus TNF-α + ADP group). C) Platelet cGMP levels (+: P < 0.05 versus control group, ***: P < 0.001 versus ADP group, ##: P
< 0.01 versus TNF-α + ADP group). D) Platelet NOS activity levels (*: P < 0.05 versus ADP group, ##: P < 0.01 versus TNF-α
+ ADP group).

addition, Cyt-c levels increased after the addition of 1400
W to TNF-α + ADP-induced platelets compared to the
TNF-α + ADP group (P < 0.01).
3.3. The effects of TNF-α on the nitric oxide metabolism
in platelets
The results of nitric oxide metabolism markers of CGMP
and total NOS activity are shown in Figures 2C and 2D.
To find out which signaling pathway might mediate the
stimulatory effects of TNF-α, platelets were pretreated
for 10 min with 50 mM and 1400 W, followed by 1 h
of incubation with TNF-α + ADP. cGMP levels in the
ADP group were decreased compared to the control
group. TNF-α increased cGMP production in ADPactivated platelets (P < 0.001). cGMP levels in platelets
were decreased for the 1400 W + TNF-α + ADP group

compared to the TNF-α + ADP group (P < 0.01). In
contrast, the ADP-activated platelets were not different in
terms of total NOS activity compared to the control group.
However, there was a reduction trend in NOS activity. A
significant increase in NOS activity was observed for the
TNF-α + ADP group compared to the ADP group (P <
0.05), and a significant decrease was observed for the ADP
+ TNF-α + 1400 W group compared to the TNF-α + ADP
group (P < 0.001).
3.4. Effects of TNF-α on the caspase-3 and iNOS gene
and protein expression in platelets
As shown in Figure 3A, caspase-3 gene expression levels
were slightly higher in ADP-activated platelets compared
to the control group (P < 0.05). Results showed that the
mRNA of caspase-3 in the TNF-α + ADP group was
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Figure 3. A) Caspase-3 gene expression in platelets determined by qRT-PCR (+: P < 0.05 versus control group, ***: P < 0.001
versus ADP group, ###: P < 0.001 versus TNF-α + ADP group). B) iNOS gene expression in platelets determined by qRT-PCR
(**: P < 0.01 versus ADP group, #: P < 0.05 versus TNF-α + ADP group).

significantly higher than in the ADP group (P < 0.001).
Treatment with 1400 W showed the highest reduction
in caspase-3 gene expression. These observations were
consistent with the results derived from real-time RTPCR (P < 0.001). iNOS gene expression levels of the
platelets are shown in Figure 3B. iNOS gene expression
in ADP-activated platelets was slightly higher than in the
control platelets, although the results were not statistically
significant. After presenting TNF-α in ADP-activated
platelets, iNOS gene expression levels were significantly
higher (P < 0.01). iNOS gene expression levels decreased
with the addition of 1400 W in the TNF-α + ADP group
(P < 0.05).
Caspase-3 and iNOS protein expressions detected with
western blotting are shown in Figure 4A. β-Actin was used
as an internal control. The data are presented as mean
± SD, performed in triplicate. Caspase-3 is expressed as
an inactive 32-kDa precursor, of which the p20 and p11
subunits are proteolytically generated during the onset
of apoptosis. Western blot analysis of the p11 subunit of
the cleaved caspase-3 showed an 11-kDa band in ADPstimulated platelets. The p11 subunit of the cleaved
caspase-3 bands was greater in the TNF-α + ADP group
compared to the ADP group. Caspase-3 protein expression
of ADP-activated platelets was significantly elevated
compared to the control group, indicating activationinduced apoptosis (P < 0.05; Figure 4B). After TNF-α,
there was a significant difference in the protein expression
of caspase-3 of the platelets compared to the ADP group
(P < 0.01). On the other hand, TNF-α induced an increase
in caspase-3 and it was significantly depressed upon the
addition of 1400 W in the TNF-α + ADP group (P < 0.001).
Western blot analysis of iNOS revealed clear 130-kDa
bands in the TNF-α + ADP-incubated platelets and only
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faint bands for 1400 W incubation in the TNF-α + ADP
group (Figure 4A). There was no change in iNOS protein
expression levels in ADP-activated platelets compared to
the control group (Figure 4C). The level of iNOS protein
expression in TNF-α + ADP-induced platelets was
significantly higher than in ADP-activated platelets (P <
0.001). In contrast, iNOS protein expression levels were
relatively decreased when 1400 W was added to TNF-α +
ADP incubated platelets (P < 0.001).
4. Discussion
Platelets, known as anucleated cells, are able to undergo
programmed cell death in response to diverse stimulants.
Platelets arise from the intrinsic apoptotic pathway
characterized by depolarization of mitochondrial inner
transmembrane potential and express several components
of the apoptotic machinery, such as activation of caspase-3,
caspase-8, and caspase-9; PS externalization and shedding
of microparticles; and proapoptotic protein expression
of Bax and Bcl-2 (Leytin et al., 2009; Vogler et al., 2011).
Platelet apoptosis and activation have been determined
through well-known markers of these platelet responses by
flow cytometry as PS externalization and CD62p exposure,
respectively (Gyulkhandanyan et al., 2012). P-selectin
is stored in α-granules of platelets, rapidly expressed on
the platelet cell surface during activation. CD62p acts as
a ligand to generate proinflammatory and procoagulatory
platelet–leukocyte aggregates (Michelson et al., 1996).
Our findings demonstrated that CD62p and PS expression
levels in platelets increased in the presence of TNF-α.
Induction of platelet PS exposure and microparticle
release is generally linked to a Ca-dependent mechanism.
Intercellular calcium signaling is a common form of cell–
cell interaction that enables tissue coordination of cell
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Figure 4. A) Activation of caspase-3 and iNOS protein expression by TNF-α in ADP-stimulated platelets determined by western
blotting. B) Caspase-3/β-actin ratio in the platelets (+: P < 0.05 versus control group, **: P < 0.01 versus ADP group, ###: P <
0.001 versus TNF-α + ADP group). C) iNOS/β-actin ratio in the platelets (***: P < 0.001 versus ADP group, ###: P < 0.001 versus
TNF-α + ADP group).

proliferation, differentiation, and metabolism (Resende et
al., 2013). In the presence of proinflammatory cytokines,
such as interleukin-1, IFN-γ, and TNF-α, inducible Ca2+independent NOS is expressed in vascular smooth muscle
cells, leading to persistent generation of large quantities of
NO (Yan et al., 1996). It is known that TNF-α can induce
Ca2+ oscillation, which is set into action by reducing Ca2+
signaling pathways (Yarilina et al., 2011). Previous studies
have demonstrated that ADP-activated platelets oscillate
Ca2+, and the efficiency by which Ca2+ signals are spread
within the platelet aggregates plays an important role in
thrombus growth (Nesbitt et al., 2003). Although Ca2+
is known as a key promoter of cell survival, this ion can
also stimulate the apoptotic machinery in response to
some pathological situations (Hajnoczky et al., 2003).

Our findings demonstrated that TNF-α triggers Ca2+
oscillation in ADP-activated platelets. Blood platelets do
not have nuclei and thus do not have the ability to regulate
protein expression transcriptionally; however, platelets
include high levels of mRNA when differentiation from
megakaryocytes occurs. Because platelets have a greater
capacity for protein synthesis, they generate NO when
activated by agonists such as adenosine diphosphate,
collagen, thrombin, and von Willebrand factor, whereas
NO release is lacking in unstimulated platelets (Freedman
et al., 1999; Böhmer et al., 2015). We have recently shown
that ADP can induce oxidative stress in platelets and
activates NOS, which plays an important role in NO
synthesis during platelet activation and in stimulation and
apoptosis (Sener et al., 2013). Previous studies have shown
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that low levels of iNOS were detected in platelets, yet its
functional state remained unknown (Wallerath et al.,
1997; Marjanovic et al., 2008; Smolenski, 2012). Indeed,
we have detected iNOS mRNA expression in human
platelets by qRT-PCR. NO production in platelets occurs
with TNF-α incubation after ADP addition and is followed
with changes in iNOS protein expression levels, denoting
a signaling-mediated functional activation mechanism
of iNOS. Considerably, iNOS inhibitors reduce TNF-α
+ ADP-induced cGMP levels in platelets, showing that
iNOS activation is critical in stimulating the presence of
TNF-α. There are several studies suggesting that TNF-α
modulates iNOS expression in a variety of cell types (Heba
et al., 2001; Nandi et al., 2010). Here we showed that NO
synthesis during platelet activation is also mediated by
the constitutively expressed iNOS protein in platelets.
On the other hand, it is known that iNOS could produce
excessive amounts of NO, whereas nNOS and eNOS could
contribute to the production of low levels of NO (Mehta
et al., 1995). The functional roles of NOS are different in
platelets; for instance, eNOS precludes interactions in
the platelet vessel wall and inhibits platelet aggregation,
whereas high levels of NO produced from iNOS can
trigger oxidative modifications and apoptosis (Osbom et
al., 2002; Marjanovic et al., 2008; Sener et al., 2012). It has
been reported that NO can regulate P-selectin expression
(Keh et al., 1996). In addition, some NOS inhibitors can
elevate platelet activation (Armstead et al., 1997). This
may be clinically important, as some researchers suggest
that levels of NO metabolites and P-selectin expression are
linked in platelets (Minamino et al., 1998). In our study, it is
confirmed that NOS activation was enhanced with TNF-α
incubation in platelets at the same time as expression of
iNOS protein increased during platelet activation with
TNF-α. Inhibition of the iNOS activity with 1400 W also
blocked the decrease in intracellular cGMP, Ca2+, Cyt-c,
and NOS levels in this study.
We investigated whether inflammation-induced
activation of the iNOS pathway is associated with
increased caspase activity and apoptosis. Recent studies
demonstrated that there is a synergistic signaling
relationship between iNOS and caspase-3 when incubated
with some stimulators in a variety of cell types (Andersson
et al., 2006; Kiang et al., 2007; Lukes et al., 2008). Caspase-3
is a member of the cysteine-aspartic acid protease family
that mediates apoptotic cell death. Regarded as an apoptotic
marker, caspase-3 activation is an essential component
of many downstream caspases involved in the apoptotic
cascade as a determinant in platelet thrombopoiesis
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(Çevik et al., 2012). Intrinsic programmed cell deathcharacterized proteins contain Cyt-c, which mediates
the activation of caspase-9 and triggers the stimulation
of a cytosolic caspase complex, including caspase-3
activation, which promotes cellular apoptosis (Li et al.,
1997). Cyt-c is released from the mitochondria into the
cytosol during programmed cell death and, additionally,
platelets express caspase-3, caspase-9, Apaf-1, and
members of the Bcl-2 family (Bertino et al., 2003). We
report that TNF-α incubation for 1 h with ADP in human
platelets induced caspase-3 protein and gene expression,
depending on the rise of both Cyt-c and Ca2+ levels.
Processing/activation of platelet caspase-3 can be induced
by several characterized platelet agonists (Josefsson et al.,
2012). Our results are in agreement with previous studies
reporting activation of caspase-3 gene expression by ADP
(Keh et al., 1996). A number of studies have established
that large agonist concentrations provoke early and late
caspase-3 activation in apoptosis. Furthermore, agonists
at physiological concentrations induce rapid caspase-3
activation independently of the apoptotic pathway that
contains Cyt-c, caspase-9, and PS exposure (Shcherbina
et al., 1999; Rosado et al., 2003; Böing et al., 2008). On
the other hand, caspases are activated in TNF-α-induced
cell death, especially activation of caspase-3, known as an
executioner. TNF-α can initiate the release of cytosolic
Cyt-c, which leads to the activation of caspase-9, evidence
that the cell death is mitochondria-dependent (Zhao et
al., 2001; Utaisincharoen et al., 2009; Alvarez et al., 2011).
Recent studies have suggested that TNF activates platelet
caspases via TNF-R1 and demonstrated the correlation
between the activation of platelets and thrombocytopenia
(Piguet et al., 2002; Yang et al., 2010). As a result, TNF-α
significantly induced the cytosolic release of Cyt-c,
which contributes to gene and protein expression of
caspase-3, meaning that cell death is associated with the
mitochondria. In addition, iNOS regulates caspase-3
activation due to high NO production by iNOS in human
platelets. Our study also shows that, depending on the
triggering stimulus, a high level of platelet activation is
associated with platelet apoptosis, and the apoptotic and
activation responses may be linked to inflammation and
NO synthesis.
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